[The use of PG.F2-alpha in primary and secondary uterine inertia].
D000287:Administration, Topical; D005260:Female; D006801:Humans; D010121:Oxytocin / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000627:therapeutic use*; D014593:Uterine Inertia / Q000188:drug therapy*; D014599:Uterus / Q000187:drug effects
D011453:Prostaglandins; D010121:Oxytocin